AzTrials
AzTrials

HealthyNCT06758869

Pulse Revolution: Enhancing Metabolic Health Through the Power of Processed Chickpeas

A study testing Whole Chickpeas, Puréed Chickpeas and 100% Chickpea Flour Product in people with Healthy, run by USDA Grand Forks Human Nutrition Research Center at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this research is to test how processing can affect how one's body uses the nutrients in that food. For this study the researchers are examining how making different food products out of chickpeas, such as hummus or pasta, changes how one's body uses those foods for energy. Read more about this study

Who is it for?
Ages 19 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
What is being tested?
Whole Chickpeas, Puréed Chickpeas and 100% Chickpea Flour Product
Could I receive a placebo?
No, everyone receives an active treatment
How many people
204 participants
Where
1 siteUnited States
Study dates
Jan 2027to Dec 2030
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • apparently healthy adults
  • BMI >18.5 or <35 kg/m2 (healthy body weight - class I obesity)
  • ability to understand and sign the consent form
  • availability of transportation (i.e., participants must provide their own transportation to the Center)
  • non-smoking or do not use other tobacco products, including e-cigarettes
  • not taking steroid-based medications
Show all 9Show fewer
  • not planning to or currently attempting to gain or lose weight
  • not allergic to study foods
  • willing to comply with study demands

Who cannot join

  • usual pulse consumption greater than DGA recommendation
  • inability or unwillingness to consume any of the provided foods
  • more than a 10% change in body weight within the past 2 months
  • actively trying to lose weight
  • pregnancy or actively trying to get pregnant
  • lactation
Show all 13Show fewer
  • uncontrolled hypertension (systolic >160 mmHg or diastolic >100 mmHg)
  • diagnosed cardiovascular, pulmonary, skeletal and metabolic diseases
  • HbA1c ≥ 5.7%
  • complete blood count (CBC) outside of the normal range for a healthy adult
  • history of gastrointestinal (GI) disorders (including Celiac's or Crohn's disease, irritable bowel syndrome, acid reflux, ulcerative colitis, chronic constipation or diarrhea, and lactose intolerance)
  • using medications known to affect appetite, blood lipids, body composition, body weight, or food intake (appetite control drugs, steroids)
  • cannot read or understand English

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Shanon Casperson, PhD contact

701-795-8497

shanon.casperson@usda.gov

United States1 site
  • USDA Grand Forks Human Nutrition Research Center

    Grand Forks, North Dakota, 58203

    Angela Scheett, 701-795-8386, angela.scheett@usda.gov

Other trials in United States

About this study

Official title: Effects of Daily Consumption of Processed Pulse-based Food Products on Physiological Responses Related to Energy Metabolism and Metabolic Health

The purpose of this research is to test how processing can affect how one's body uses the nutrients in that food. For this study the researchers are examining how making different food products out of chickpeas, such as hummus or pasta, changes how one's body uses those foods for energy.

Read the detailed description

The overall objective is to determine the impact of daily consumption of processed pulse-based food products on metabolic health, specifically the physiological responses related to energy metabolism. The primary hypothesis is that consuming a serving of pulses daily for 12 weeks will improve metabolic responses related to energy metabolism, particularly fat oxidation and molecular adaptations related to fat and glucose metabolism, compared to current Dietary Guidelines for Americans (DGA) recommendations. Furthermore, we hypothesize that the degree of processing will influence these metabolic adaptations such that the daily consumption of 100% pulse flour food products will result in the greatest effect on fat oxidation and molecular adaptations related to fat and glucose metabolism followed by the pulse purée which will have a greater effect than the whole cooked pulse (100% pulse flour > purée > whole).

Conditions
Healthy
Being tested
Control, Whole Chickpeas, Puréed Chickpeas, 100% Chickpea Flour Product

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ControlOther

    Participants will consume the Base DGA diet with a standardized non-pulse product snack.

  • Whole ChickpeasOther

    Participants will consume an adjusted DGA diet with a standardized whole chickpea snack.

  • Puréed ChickpeasOther

    Participants will consume an adjusted DGA diet with a standardized puréed chickpea snack.

  • 100% Chickpea Flour ProductOther

    Participants will consume an adjusted DGA diet with a standardized 100% chickpea flour product snack.

Study groups in NCT06758869
Study groupRoleWhat they receive
ControlExperimentalBase DGA diet with a standardized non-pulse product snack
Receives: Other: Control
Whole ChickpeasExperimentalAdjusted DGA diet with standardized whole chickpea snack
Receives: Other: Whole Chickpeas
Puréed ChickpeasExperimentalAdjusted DGA diet with standardized puréed chickpea snack
Receives: Other: Puréed Chickpeas
100% Chickpea Flour ProductExperimentalAdjusted DGA diet with standardized 100% chickpea flour product snack
Receives: Other: 100% Chickpea Flour Product

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in substrate oxidation in response to eating differentially processed pulse-based food products

    Using whole-room calorimetry, measure differences in fat, carbohydrate, and protein oxidation in response to daily consumption of whole chickpeas, pureed chickpeas, or chickpea-flour pasta compared to a control diet.

    Measured: 12 weels

  2. Change from Baseline in substrate oxidation after consuming differentially processed pulse-based food products for 12 weeks

    Measure changes in fat, carbohydrate, and protein oxidation in response to consuming whole chickpeas, pureed chickpeas, or chickpea-flour pasta using whole room calorimetry

    Measured: 12 weeks

  3. Determine participant consumption practices and attitudes towards pulse consumption using a validated questionnaire

    The questionnaire is designed to assess enjoyment (two items), sensory properties (eight items), perceived cooking abilities (ten items), perceived practical aspects (six items), perceived healthiness (two items), upbringing (two items), social influences (four items), and quality issues (six items) of pulse consumption.

    Measured: Baseline

Secondary outcomes (2)
  1. Changes in the colonic microbiota in response to consuming differentially processed pulse-based food products

    Fecal samples will be collected at Baseline and then again at weeks 4, 8, and 12 to identify how the predominant colon bacteria phyla are effected by consuming whole chickpeas, pureed chickpeas, or chickpea-flour pasta for 12 weeks.

    Measured: 12 weeks

  2. Changes in me metabolic gene expression and metabolites in response to consuming differentially processed pulse-based food products.

    Blood samples will be collected before and after consuming whole chickpeas, pureed chickpeas, or chickpeas-flour pasta for 12 weeks to identify how consuming these foods effect the expression genes involved with fat metabolism. This will be accomplished by combining the different snapshots provided from pre/post intervention metabolomic, transcriptomic, and proteomic analysis.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2025
  2. Study startJan 2027 (estimated)
  3. Primary completionDec 2030 (estimated)
  4. Study completionDec 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
204 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06758869
Sponsor's protocol ID
GFHNRC514
Status last verified
Oct 2026
First submitted
19 Dec 2024
Last updated
13 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Whole Chickpeas, Puréed Chickpeas and 100% Chickpea Flour Product in people with Healthy, run by USDA Grand Forks Human Nutrition Research Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Shanon Casperson, PhD (701-795-8497, shanon.casperson@usda.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in substrate oxidation in response to eating differentially processed pulse-based food products (time frame: 12 weels). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in